PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 90 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $909,000 | -23.1% | 300,000 | 0.0% | 0.09% | +13.9% |
| Q4 2021 | $1,182,000 | -23.8% | 300,000 | 0.0% | 0.08% | -27.5% |
| Q3 2021 | $1,551,000 | +35.0% | 300,000 | 0.0% | 0.11% | +39.7% |
| Q2 2021 | $1,149,000 | +49.0% | 300,000 | 0.0% | 0.08% | +44.4% |
| Q1 2021 | $771,000 | +2.8% | 300,000 | 0.0% | 0.05% | -11.5% |
| Q4 2020 | $750,000 | +20.8% | 300,000 | 0.0% | 0.06% | +10.9% |
| Q3 2020 | $621,000 | -33.2% | 300,000 | 0.0% | 0.06% | -45.0% |
| Q2 2020 | $930,000 | +36.0% | 300,000 | 0.0% | 0.10% | +4.2% |
| Q1 2020 | $684,000 | -37.0% | 300,000 | 0.0% | 0.10% | -19.3% |
| Q4 2019 | $1,086,000 | +6.2% | 300,000 | 0.0% | 0.12% | -7.0% |
| Q3 2019 | $1,023,000 | -27.4% | 300,000 | 0.0% | 0.13% | -17.4% |
| Q2 2019 | $1,410,000 | +40.3% | 300,000 | 0.0% | 0.16% | +31.4% |
| Q1 2019 | $1,005,000 | +25.9% | 300,000 | 0.0% | 0.12% | +29.7% |
| Q4 2018 | $798,000 | -52.5% | 300,000 | 0.0% | 0.09% | -45.8% |
| Q3 2018 | $1,680,000 | +10.5% | 300,000 | 0.0% | 0.17% | +7.7% |
| Q2 2018 | $1,521,000 | -25.7% | 300,000 | 0.0% | 0.16% | -38.1% |
| Q1 2018 | $2,046,000 | – | 300,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |